Praxis Precision Medicines (PRAX) earnings
In the quarter ended June 2026, Praxis Precision Medicines had revenue of —, and diluted EPS of -2.87.
On August 6, 2026 it reported EPS of -2.87 against an estimate of -3.60 (beat).
The next report is expected on Monday, November 9, 2026 before the market opens, with EPS expected around -3.66.
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Next | Mon Nov 9, 2026 | Before open | -3.66 | — |
| Last | Thu Aug 6, 2026 | — | -3.60 | -2.87 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Praxis Precision Medicines's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | -2.87 | — | — | 2026-08-06 |
| Mar 31, 2026 | — | — | -3.20 | — | — | 2026-05-07 |
| Dec 31, 2025 | $0 | — | — | — | — | 2026-02-19 |
| Sep 30, 2025 | $0 | — | -3.36 | — | — | 2025-11-05 |
| Jun 30, 2025 | $0 | — | -3.31 | — | — | 2025-08-04 |
| Mar 31, 2025 | $0 | — | -3.29 | — | — | 2025-05-02 |
| Dec 31, 2024 | $7M | +1349.1% | — | — | -857.0% | 2025-02-28 |
| Sep 30, 2024 | $302,000 | -35.5% | -2.75 | — | -18819.5% | 2024-11-06 |
| Jun 30, 2024 | $357,000 | -54.3% | -1.74 | — | -10500.8% | 2024-08-13 |
| Mar 31, 2024 | $431,000 | -36.9% | -2.84 | — | -9718.3% | 2024-05-13 |
| Dec 31, 2023 | $515,000 | — | — | — | -5399.2% | 2024-03-05 |
| Sep 30, 2023 | $468,000 | — | -2.72 | — | -5452.1% | 2023-11-07 |
Questions
When does Praxis Precision Medicines report earnings?
Praxis Precision Medicines's next earnings report is expected on November 9, 2026 before the market opens.
How did Praxis Precision Medicines do last quarter?
In the quarter ended June 2026, Praxis Precision Medicines had revenue of —, and diluted EPS of -2.87.
From Praxis Precision Medicines's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.